The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunotherapy with anti-GD2 antibody ch14.18/CHO±IL2 within the HR-NBL1/SIOPEN trial to improve outcome of high-risk neuroblastoma patients compared to historical controls.
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma
 
Ulrike Poetschger
No Relationships to Disclose
 
Dominique Valteau Couanet
No Relationships to Disclose
 
Juliet Gray
Consulting or Advisory Role - Roche (Inst)
 
Roberto Luksch
No Relationships to Disclose
 
Victoria Castel
Travel, Accommodations, Expenses - EUSA Pharma
 
Shifra Ash
No Relationships to Disclose
 
Genevieve Laureys
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Toby Trahair
Stock and Other Ownership Interests - CSL Limited; Pfizer
 
Godfrey Chi Fung Chan
Speakers' Bureau - Apotex; China Regenerative Medicine
Patents, Royalties, Other Intellectual Property - HKU (Inst)
Travel, Accommodations, Expenses - Apotex
 
Ellen Ruud
No Relationships to Disclose
 
Henrik Schroeder
No Relationships to Disclose
 
Maja Beck Popovic
No Relationships to Disclose
 
Hans Loibner
Employment - Apeiron Biologics
Leadership - Apeiron Biologics
Stock and Other Ownership Interests - Aprea AB
Consulting or Advisory Role - Apeiron Biologics
Patents, Royalties, Other Intellectual Property - Apeiron Biologics
Travel, Accommodations, Expenses - Apeiron Biologics
 
Guenter Schreier
No Relationships to Disclose
 
Peter F Ambros
No Relationships to Disclose
 
Sabine Sarnacki
No Relationships to Disclose
 
Tom Boterberg
No Relationships to Disclose
 
Holger N. Lode
Consulting or Advisory Role - Apeiron Biologics; EUSA Pharma